, Tracking Stock Market Picks
Enter Symbol:
Stryker Corporation (SYK) [hlAlert]

Hold SYK
up 14.32 %

Stryker Corporation (SYK) downgraded to Hold by Standpoint Research

Posted on: Tuesday,  Dec 18, 2012  2:25 PM ET by Standpoint Research

Standpoint Research rated Hold Stryker Corporation (NYSE: SYK) on 12/18/2012. Previously Standpoint Research rated Buy Stryker Corporation (NYSE: SYK) on 08/05/2011.,
when the stock price was $49.15. Since then, Stryker Corporation has gained 14.32% as of 12/18/2012's recent price of $56.19.
If you would have followed the previous Standpoint Research's recommendation on SYK, you would have gained 14.32% of your investment in 501 days.

Stryker Corporation (Stryker) is a medical technology company with a range of products in orthopaedics and a presence in other medical specialties. The Company's products include implants used in joint replacement, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose and throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. The Company operates in two business segments: Orthopaedic Implants and MedSurg Equipment. The Orthopaedic Implants segment sells orthopaedic reconstructive (hip, knee and shoulder), trauma, craniomaxillofacial and spinal implant systems; bone cement; and the bone growth factor OP-1. The MedSurg Equipment segment sells surgical equipment; surgical navigation systems; endoscopic, communications and digital imaging systems; as well as patient handling and emergency medical equipment.

Standpoint Research provides independent equity research that is free from the conflicts of asset management, investment banking, proprietary trading, and fee-for-research arrangements. We provide thorough analysis, diagnostics and forecasts on domestic and international equities and markets backed by alpha-generating variables back-tested on many years of data. Standpoint Research currently advises and sells its research to pension funds, hedge funds and asset management firms. Wall Street analysts have an optimistic bias, while we are more objective. In fact some of the variables in our model that are looked at as positives by Wall Street actually carry negative weight in our model. We have a strict discipline that includes running our proprietary 155-variable valuation and diagnostics model with a personal and subjective overlay that has been proven to add value. The effectiveness is demonstrated through our impressive track record of recommendations.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/18/2012 2:25 PM Hold
as of 12/31/2012
1 Week   
1 Month up  3.74 %
3 Months up  0.95 %
1 YTD up  13.03 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/5/2011 11:25 AM Buy
49.15 60.00
6/11/2010 10:25 AM Buy
1/19/2010 11:25 AM Hold
3/9/2009 8:25 AM Buy

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy